Insider · CIK 0001843113
John Aballi
Files at XGN (EXAGEN INC.). First filing Oct 18, 2023, latest Mar 4, 2026.
In brief
John Aballi files SEC Form 4 as CEO, president and director at XGN (EXAGEN INC.). Since Oct 18, 2023, John Aballi has reported 1 open-market buy worth $68k and 4 open-market sells worth $533k, the latest filed on Mar 4, 2026.
A track record needs three past buys with six months of prices behind them; John Aballi has 1, so none is measured yet.
The newest scored trade: sold $57k of XGN on Mar 3, 2026, filed Mar 4, 2026, scored 40 (moderate). In the last 12 months: 0 buys worth $0 and 3 sells worth $474k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
XGN: EXAGEN INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | EXAGEN INC. | $57k 15,698 shares | -2% | +20% from low-71% from high | |
| 39Weak | EXAGEN INC. | $41k 11,430 shares | -2% | +29% from low-69% from high | |
| 41Moderate | XGNsell EXAGEN INC. | $376k 31,787 shares | -4% | +384% from low-1% from high | |
| 41Moderate | EXAGEN INC. | $68k 24,305 shares | +4% | - | |
| 32Weak | XGNsell EXAGEN INC. | $59k 33,819 shares | -8% | 0% from low-52% from high |
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 12, 2026 | XGN EXAGEN INC. | AGrant or award Common Stock | +150,000 | $0.00 | $0 | 839,834 | Mar 16, 2026 |
| Mar 12, 2026 | XGN EXAGEN INC. | AGrant or award Stock Option(right to buy)derivative | +100,000 | $3.16 | $316k | 175,000 | Mar 16, 2026 |
| Mar 3, 2026 | XGN EXAGEN INC. | SOpen-market sale Common Stock | -15,698 | $3.62 | $57k | 687,299 | Mar 4, 2026 |
| Mar 3, 2026 | XGN EXAGEN INC. | AGrant or award Common Stock | +2,535 | $3.08 | $7,800 | 689,834 | Mar 4, 2026 |
| Feb 24, 2026 | XGN EXAGEN INC. | SOpen-market sale Common Stock | -11,430 | $3.61 | $41k | 702,997 | Feb 25, 2026 |
| Oct 16, 2025 | XGN EXAGEN INC. | SOpen-market sale Common Stock | -31,787 | $11.82 | $376k | 714,427 | Oct 20, 2025 |
| Feb 28, 2025 | XGN EXAGEN INC. | AGrant or award Common Stock | +8,621 | $2.47 | $21k | 746,214 | Mar 4, 2025 |
| Feb 21, 2025 | XGN EXAGEN INC. | AGrant or award Common Stock | +112,500 | $0.00 | $0 | 737,593 | Feb 25, 2025 |
| Feb 21, 2025 | XGN EXAGEN INC. | AGrant or award Stock Option(right to buy)derivative | +75,000 | $3.58 | $269k | 75,000 | Feb 25, 2025 |
| Nov 14, 2024 | XGN EXAGEN INC. | POpen-market purchase Common Stock | +24,305 | $2.81 | $68k | 689,799 | Nov 18, 2024 |
| Oct 17, 2023 | XGN EXAGEN INC. | SOpen-market sale Common Stock | -33,819 | $1.75 | $59k | 415,984 | Oct 18, 2023 |
Questions about John Aballi
Answered from the filings on this page, as of the latest one.
Is John Aballi buying or selling?
In the last 12 months John Aballi reported 0 open-market buys worth $0 and 3 open-market sells worth $474k on SEC Form 4; the latest was sold $57k of XGN on Mar 3, 2026. Grants, option exercises and tax withholding are not counted.
How did John Aballi's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and John Aballi has 1.
Where does John Aballi file Form 4?
John Aballi has filed Form 4 at XGN (EXAGEN INC.) as President and CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.